Browsing: China

Beijing-based Haoxi Health Technology Limited has announced the pricing of a $12 million underwritten follow-on public offering.

An analysis of DongHua Testing Technology (SZSE:300354) and its recent stock performance, focusing on Return on Equity (ROE) and earnings growth.

An analysis of Shandong Sito Bio-technology Co., Ltd. (SZSE:300583) reveals a disconnect between its recent stock performance and declining revenue. The high price-to-sales ratio warrants further examination.